You’ll find here the latest news and insights about Real4Reg.
If you want to receive all updates directly in your email inbox, you can subscribe to our newsletter. Additionally, feel free to explore our archive for past newsletters.
-
Use of Real World Evidence (RWE) for regulatory purposes
While randomized controlled trials (RTCs) are the gold standard for generating evidence for regulatory decision making in the product lifecycle of drugs , some of the limitations by RTCs may be addressed by the use of real world evidence (RWE). RWE is information derived from the analysis of real-world data (RWD). While internal validity is…
-
Real4Reg Project Holds Successful Consortium Meeting
The first Consortium meeting of the second year of the Real4Reg project took place virtually on February 27th. The meeting gathered elements from our ten partner institutions and was a productive morning filled with updates on progress, lessons learned, preliminary results and outlining forthcoming tasks. Key highlights of the meeting included:
-
Consortium Meeting Held on December 12, 2023 Promotes Collaboration and Progress
On December 12, the IV Real4Reg Consortium Meeting united the project partners for a day filled with in-depth discussions and exchanges focused on the progress of the work packages, addressing primary challenges, brainstorming ideas for overcoming obstacles, and outlining strategic plans for 2024. The afternoon session had the presence of experts from the Real4Reg Advisory…